ArticleClinical cancer research : an official journal of the American Association for Cancer Research2023

PERK Inhibition by HC-5404 Sensitizes Renal Cell Carcinoma Tumor Models to Antiangiogenic Tyrosine Kinase Inhibitors.

Michael E Stokes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.